News
Thanks to budget cuts, many potential insights and treatments needed to propel oncology forward will never be realized.
One of the Womenâs Health Initiativeâs biggest yields is its vast repository of health data collected annually from tens of thousands of women over more than 30 years. The dat ...
During a live event, Ahmad Tarhini, MD, PhD, discussed key melanoma trials with varying survival and toxicity profiles.
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") announced today that HonorHealth, a leading healthcare system serving more than five million people in the ...
NeuroSense Therapeutics Ltd. ("NeuroSense"), a late-stage clinical biotechnology company developing novel treatments for severe neurodegenerative diseases, today issued a shareholder letter from Chief ...
Key players like Bayer AG and Fusion Pharmaceuticals are driving innovation in radioligand and alpha-particle therapies, addressing crucial market challenges such as radioisotope supply chain ...
In addition to setting forth requirements regarding the general use of AI in the claims process, SB 1120âs focal point is a ...
Hosted on MSN16d
Frog vs. Snake: The Outcome Will Shock You! âď¸Frog vs. Snake: The Outcome Will Shock You! đâď¸đ¸ Posted: 19 April 2025 | Last updated: 19 April 2025 Most people think frogs are harmless bug-chompers but this shocking amphibian flips ...
Patients who undergo catheter ablation for atrial fibrillation (AFib) who also have heart failure with preserved ejection fraction (HFpEF) experienced a greater benefit from ablation in terms of ...
âProgynyâs unique model, unparalleled clinical outcomes, and commitment to high-touch care are ... womenâs health space at scale,â said Clapp âIâm excited to bring my years of experience in leading ...
AptarGroup (ATR) announced the commencement of a clinical study to validate its proprietary SmartTrack platform. The platform was developed by Aptarâs drug services company, Nanopharm.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results